Delivery Order SPE2DB20D2014-SPE2DB24FA91Q
- Not listed
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 contract has a completion date of February 28, 2024 and was awarded on February 6, 2024. Amerisourcebergen Drug Corp holds a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical as the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,530.60 fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty pharmaceutical product. The contract has an ultimate completion date of September 12, 2024 and is not designated as a set-aside. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The $4,530.60 firm-fixed-price delivery order contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a specialty medication. The contract is not set aside and has an ultimate completion date of October 15, 2024. It is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract, valued at $6,795.87, has an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and has a parent company, Cencora, Inc., which is also doing business as Amerisourcebergen. This delivery order...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has a potential value of $4,530.60 and a completion date of February 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and there are no set-aside designations mentioned. This delivery order is part of a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,687.18, is a delivery order for the medical product "TEZSPIRE 210 MG/1.91 ML PEN 1.91ML." The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The $4,530.60 delivery order has a completion date of February 5, 2024 and was awarded on January 12, 2024. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor and has previously received multiple federal contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm-fixed-price delivery order is for the supply of the medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a period of performance through June 5, 2025. The contract is not set aside and represents an open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has an ultimate completion date of May 2, 2024 and a ceiling value of $6,795.87. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that AmerisourceBergen Drug Corp holds with DLA,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation. The $4,530.60 order is for the medication TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, with a completion date of March 7, 2024. Amerisourcebergen Drug Corp, a for-profit organization, holds an indefinite delivery contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025 to...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA91QDelivery Order
This federal contract was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,530.60 firm fixed price delivery order is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a prime contractor providing a wide range of pharmaceutical products and medical supplies to U.S. government agencies, primarily the Department of Defense through DLA Troop Support Medical. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA, which serves as the primary contract vehicle for Amerisourcebergen to deliver pharmaceuticals and medical materials to military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 1/26/24 |